Coronary artery disease test from GE-backed CardioDx gets mixed results in trial
This article was originally published in Clinica
Executive Summary
A trial designed to validate the ability of Corus CAD, CardioDx's gene expression test for coronary artery disease (CAD) has backed the product, but only weakly.